European Monitoring Centre for Drugs and Drug Addiction, & Inter-American Drug Abuse Control Commission of the Organization of American States. (2010). Building a national drugs observatory : a joint handbook. Joint publications. Luxembourg: Office for Official Publications of the European Communities.
Abstract: National drugs observatories have flourished and developed rapidly over the last two decades as a direct consequence of the decisions taken to establish regional drug monitoring systems, both in the European Union and in the Americas. Initially, there was no reference framework available — observatories were set-up using trial and error, taking into account different national contexts and resources. This explains why today there are as many models of observatories as there are countries establishing them. Looking back at this long process, there seemed to be a need to formalise the experiences in the field, and to identify some key concepts and principles that remain valid irrespective of country or region. This handbook, a joint production by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the Inter-American Drug Abuse Control Commission of the Organization of American States (CICAD–OAS), presents and describes in a clear and informative way the core operational processes and the key strategic factors that are common to all national drugs observatories.
Keywords: monitoring; drug; organizational structure; administration and management; Europe; Americas; international area
|
Observatoire européen des drogues et des toxicomanies, & Commission interaméricaine de lutte contre l'abus des drogues de l'Organisation des États américains (Eds.). (2010). Création d'un observatoire national des drogues : manuel conjoint. Joint publications. Luxembourg: Office des publications officielles des Communautés européennes.
Abstract: National drugs observatories have flourished and developed rapidly over the last two decades as a direct consequence of the decisions taken to establish regional drug monitoring systems, both in the European Union and in the Americas. Initially, there was no reference framework available — observatories were set-up using trial and error, taking into account different national contexts and resources. This explains why today there are as many models of observatories as there are countries establishing them. Looking back at this long process, there seemed to be a need to formalise the experiences in the field, and to identify some key concepts and principles that remain valid irrespective of country or region. This handbook, a joint production by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the Inter-American Drug Abuse Control Commission of the Organization of American States (CICAD–OAS), presents and describes in a clear and informative way the core operational processes and the key strategic factors that are common to all national drugs observatories.
Keywords: monitoring; drug; organizational structure; administration and management; Europe; Americas; international area
|
European Monitoring Centre for Drugs and Drug Addiction. (2010). General report of activities 2009 : including “Annual report of the EMCDDA's authorising officer”. General report of activities. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The General report of activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme. The report is a useful information source for all those seeking comprehensive information on the Centre and its work.
Keywords: monitoring; administration and management; cost-effectiveness; cooperation; communication; quality control; assessment; international area; Europe; annual report
|
Olszewski, D., Bo, A., & Burkhart, G. (2010). Children's voices : experiences and perceptions of European children on drug and alcohol issues (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Luxembourg: Office for Official Publications of the European Communities.
Abstract: The purpose of this paper is to give meaning and insight into some of the key drug and alcohol issues that affect children from the perspectives of the children themselves. It is not to estimate the relative magnitude of a specific drug or alcohol problem or the numbers of children affected by it. Each section of this paper is preceded by one or two key statistics and whilst the quotations that follow may highlight a need to develop more robust and detailed statistics on a key issue, the overriding objective is to give the children a voice.
Keywords: addiction; AOD dependence; chemical addiction; AOD use; statistical data; child; parent; family; foster care; AOD consumption; intervention (persuasion to treatment); Europe
|
Rhodes, T., & Hedrich, D. (2010). Harm reduction : evidence, impacts and challenges. Monographs, 10. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The EMCDDA’s 10th scientific monograph, entitled Harm reduction: evidence, impacts and challenges provides a comprehensive overview of the harm reduction field. Part I of the monograph looks back at the emergence of harm reduction approaches and their diffusion, and explores the concept from different perspectives, including international organisations, academic researchers and drug users. Part II is dedicated to current evidence and impacts of harm reduction and illustrates how the concept has broadened to cover a wide range of behaviours and harms. Part III addresses the current challenges and innovations in the field. The core audience of the monograph comprises policymakers, healthcare professionals working with drug users, as well as the wider interested public.
Keywords: harm reduction; history; cooperation; research; drug user; public policy on illicit drugs; international area; Europe
|
European Monitoring Centre for Drugs and Drug Addiction. (2010). Work programme 2010. Work programmes and strategies. Luxembourg: Publications Office of the European Union.
Abstract: The 2010 work programme is the first to fall under the EMCDDA’s new three-year strategy and work programme (2010–12). In terms of substantive technical activities, the three-year strategy aims to consolidate the core data sets held by the agency and enable more complex analysis of them. It also scales up and develops some new areas of strategic importance. This means that 2010 will necessarily be a formative and exploratory year during which the structures and approaches needed to deliver the objectives set out in the work programme are put in place.
Keywords: government and politics; monitoring; AOD use, abuse, and dependence; international area; Europe
|
Burkhart, G. (2010). Prevention and evaluation resources kit (PERK) : a manual for prevention professionals (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Manuals. Luxembourg: Office for Official Publications of the European Communities.
Abstract: This manual compiles basic but evidence-based prevention principles, planning rules and evaluation tips. Additionally, it provides related documentation or references for download; it is hoped that this additional material will be particularly useful for readers who have difficulty accessing the scientific prevention literature. To illustrate the theoretical discussion, an intervention example, partly based on a real-life situation, gives a practical perspective.
Keywords: prevention; assessment; program planning, implementation, and evaluation; program planning; program implementation; program evaluation; prevention outcome; training manual
|
various. (2007). Guidelines for the evaluation of treatment in the field of problem drug use : a manual for researchers and professionals (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Manuals, 3. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The main objective of the guidelines is to provide a European audience with basic information on the options, elements and procedures of drug-related treatment evaluation. The target readership includes professionals working in treatment services for substance use and dependence, administrators and officials in social and health authorities, researchers dealing with treatment of substance dependence, and those who professionally or politically may have an interest in evidence from treatment evaluation.
Keywords: research; government and politics; treatment and maintenance; addiction; AOD dependence; chemical addiction; diagnosis; recommendations or guidelines; Europe
|
various. (2010). Guidelines for testing HIV, viral hepatitis and other infections in injecting drug users (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Manuals, 6. Luxembourg: Office for Official Publications of the European Communities.
Abstract: Infectious diseases are among the most serious health consequences of injecting drug use and can lead to significant healthcare costs. Injecting drug users are vulnerable to a range of infectious and communicable diseases through a variety of risk behaviours, and because of underlying conditions such as poor hygiene, homelessness and poverty. There is a recognised need for guidance on providing IDUs with a medical examination and testing for HIV, viral hepatitis and several other infections on a regular basis. In addition, improving testing uptake in this group would benefit epidemiological surveillance and monitoring as carried out at the national and international level. These guidelines are accompanied by a recommended package of prevention and primary care in relation to injecting drug users and infections. Treatment and other specialist care are not discussed in detail but are dealt with by indicating referral to appropriate services.
Keywords: addiction; AOD use, abuse, and dependence; chemical addiction; health; prevention; primary health care; communicable disease; intravenous drug user; risk-taking behavior; viral hepatitis; HIV infection; social services; recommendations or guidelines; Europe
|
various. (2010). Guidelines for collecting data on retail drug prices in Europe : issues and challenges (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Manuals, 5. Luxembourg: Office for Official Publications of the European Communities.
Abstract: Prices are an essential element of the illicit drug market, from both a supply and demand perspective. They are an indicator of drug availability and are an important tool for understanding the workings of drug supply mechanisms. They may also be used to help target law enforcement resources and assist criminal justice agencies with decisions related to prosecution and sentencing (e.g. assets recovery). The EMCDDA has been collecting information on retail drug prices via its Reitox focal points for the last 15 years. Although considerable progress has been made in this area, there is still variation in data collection in Europe. To address this issue, the EMCDDA has released these Guidelines for collecting data on retail drug prices in Europe: issues and challenges in its Manuals series. The Manual raises awareness on specific issues related to collecting data on retail drug prices and offers practical suggestions. It addresses difficulties in obtaining a definition of ’retail’ prices, and discusses the challenge of obtaining a representative sample of illicit, and therefore hidden, transactions. Suggestions are made for a minimum set of variables to be recorded for each observation. Targeted at all those involved in data collection on drug prices in Europe, the Manual reviews the main data-collection methods, current national practices and data-management issues.
Keywords: research; data collection; price and pricing; illicit drug; recommendations or guidelines; Europe
|
